GB Patent
GB9319732D0 — Use of (s)-alpha-ethyl-2-oxo-l-pyrrolidineacetamide for the treatment of anxiety
Assigned to UCB SA · Expires 1993-11-10 · 33y expired
What this patent protects
Use of (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidineacetamide of formula <IMAGE> as a medicament for the treatment of anxiety.t
USPTO Abstract
Use of (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidineacetamide of formula <IMAGE> as a medicament for the treatment of anxiety.t
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.